Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
NCT00320398 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 114
Last updated 2018-09-04
Summary
This study is requested by PMDA to confirm the optimal dose for THR (total hip replacement).
Conditions
- Thrombosis, Venous
Interventions
- DRUG
-
Fondaparinux
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-30
- Primary Completion
- 2006-07-18
- Completion
- 2006-07-18
Countries
More Related Trials
-
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
NCT00423319 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
NCT01203098 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
NCT01444612 ·Status: COMPLETED
-
The Treatment of Acute Pulmonary Thromboembolism (PE) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
NCT00981409 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery
NCT00398216 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery
NCT00697099 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery
NCT00306254 ·Status: COMPLETED ·Phase: PHASE2
-
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
NCT00541320 ·Status: WITHDRAWN ·Phase: PHASE2
-
Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery
NCT00767559 ·Status: UNKNOWN ·Phase: NA
-
Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection
NCT01420809 ·Status: COMPLETED
-
A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis
NCT00789399 ·Status: TERMINATED ·Phase: NA
-
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
NCT00531843 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)
NCT00349180 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
NCT01181167 ·Status: COMPLETED ·Phase: PHASE3
-
New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery
NCT00074828 ·Status: COMPLETED ·Phase: PHASE2
-
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT05752461 ·Status: COMPLETED ·Phase: PHASE2
-
Dabigatran Etexilate in Extended Venous Thromboembolism (VTE) Prevention After Hip Replacement Surgery
NCT00168818 ·Status: COMPLETED ·Phase: PHASE3
-
Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal General Surgery
NCT01390896 ·Status: COMPLETED
-
Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA
NCT01139658 ·Status: COMPLETED
-
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
NCT01809054 ·Status: COMPLETED ·Phase: PHASE4
-
Fondaparinux as Monotherapy for DVT and/or Pulmonary Embolism
NCT00413504 ·Status: COMPLETED ·Phase: NA
-
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery
NCT00331838 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics Study of DU-176b Administered to Patients With Severe Renal Impairment Undergoing Orthopedic Surgery of The Lower Limbs
NCT01857583 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
NCT00843492 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
NCT00436787 ·Status: COMPLETED ·Phase: PHASE2